Serotonin Uptake InhibitorsFluoxetineCitalopramParoxetineSerotoninAntidepressive Agents, Second-GenerationAntidepressive AgentsFluvoxamineAntidepressive Agents, TricyclicSertralineSerotonin Plasma Membrane Transport ProteinsCyclohexanolsAdrenergic Uptake InhibitorsSerotonin SyndromeReceptor, Serotonin, 5-HT1ADepressive DisorderReceptors, SerotoninDepressive Disorder, MajorSerotonin AntagonistsReceptors, Serotonin, 5-HT1ClomipramineReceptor, Serotonin, 5-HT2ANeurotransmitter Uptake InhibitorsSerotonin Receptor AgonistsObsessive-Compulsive DisorderPremenstrual SyndromeDepressionDesipramineSerotonin 5-HT1 Receptor Antagonists1-NaphthylamineReceptor, Serotonin, 5-HT1BDothiepinLofepramine8-Hydroxy-2-(di-n-propylamino)tetralinSerotonergic NeuronsSerotonin AgentsSerotonin 5-HT2 Receptor AntagonistsReceptors, Serotonin, 5-HT2Raphe NucleiSerotonin 5-HT1 Receptor AgonistsMaprotilineFenfluramineTryptophan HydroxylaseBehavior, AnimalAnti-Anxiety AgentsDrug InteractionsNorepinephrine Plasma Membrane Transport ProteinsMonoamine Oxidase InhibitorsMianserinToxicity Tests, SubacuteAnxiety DisordersSerotonin 5-HT4 Receptor AgonistsSuicideTreatment OutcomePsychiatric Status Rating ScalesMicrodialysisSwimmingDouble-Blind MethodCognitive TherapyPregnancy ComplicationsNortriptylineReceptor, Serotonin, 5-HT2CDose-Response Relationship, DrugRats, Sprague-DawleyAmitriptylineAnxietyDepressive Disorder, Treatment-ResistantPiperazinesAntipsychotic AgentsSexual Dysfunction, Physiological5,7-Dihydroxytryptamine5-HydroxytryptophanPanic DisorderBrainAutoreceptorsPatient DropoutsImipramineReceptor, Serotonin, 5-HT2BPropylaminesDroxidopaPregnancy TrimestersMoclobemideThiophenesDopamine Uptake InhibitorsNorepinephrinePhenelzineBiogenic MonoaminesBupropionRandomized Controlled Trials as TopicMotor ActivityPsychotherapyPsychotropic DrugsAnalysis of VarianceDepersonalizationAlprazolamPlacebosImmobility Response, TonicCytochrome P-450 CYP2D6Membrane Transport ProteinsHindlimb Suspension